vTv Therapeutics Inc. Share Price & Technical Analysis
VTVT · $34.41 (-3.07%)
Healthcare / Biotechnology
$34.41
-3.07%
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company …
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
8% return in May, -10% avg return in past 3 year May month.
-14% return in 2026, 60% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -12% | 6% | 4% | -20% | 8% | – | – | – | – | – | – | – | -14% |
| 25 | 18% | 25% | -7% | 16% | -20% | -6% | 3% | 11% | 38% | -4% | 32% | 56% | 163% |
| 24 | -28% | 116% | 37% | 19% | -15% | -23% | -23% | 10% | -8% | 1% | 12% | -12% | 86% |
| 23 | 40% | -11% | 0% | -5% | 4% | -7% | -8% | -24% | -4% | -13% | -21% | -19% | -69% |
| 22 | -30% | 12% | -14% | -5% | -19% | -15% | 18% | 18% | -6% | -11% | -4% | -22% | -78% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Neutral
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$126.63M
P/E ratio
—
52W high
$44.00
52W low
$14.00
Volume
60,463
Beta
0.26
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is vTv Therapeutics Inc. share price today?
- vTv Therapeutics Inc. (VTVT) last traded around $34.41 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does VTVT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for VTVT. Download the app for real-time alerts.
- How can I analyze vTv Therapeutics Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.